The Therapeutic Goods Administration (TGA) has approved Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.
The Australian Technical Advisory Group on Immunisation (ATAGI) is yet to make a decision on which under-fives will be eligible.
